LEAM versus CBV for conditioning in autologous hematopoietic stem cell transplantation for lymphoma

Bone Marrow Transplant. 2019 Apr;54(4):625-628. doi: 10.1038/s41409-018-0349-4. Epub 2018 Oct 3.
No abstract available

Publication types

  • Clinical Trial, Phase I
  • Clinical Trial, Phase II
  • Letter
  • Multicenter Study

MeSH terms

  • Adult
  • Antineoplastic Combined Chemotherapy Protocols / administration & dosage
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Carmustine / administration & dosage
  • Cyclophosphamide / administration & dosage
  • Doxorubicin / administration & dosage
  • Etoposide / administration & dosage
  • Female
  • Hematopoietic Stem Cell Transplantation / methods*
  • Humans
  • Lomustine / administration & dosage
  • Lymphoma / drug therapy
  • Lymphoma / therapy*
  • Male
  • Methotrexate / administration & dosage
  • Prednisolone / administration & dosage
  • Prospective Studies
  • Transplantation Conditioning / methods*
  • Transplantation, Autologous

Substances

  • Etoposide
  • Lomustine
  • Doxorubicin
  • Cyclophosphamide
  • Prednisolone
  • Carmustine
  • Methotrexate

Supplementary concepts

  • CBV protocol
  • LEAMP protocol